COM:DISCMEDICINE
Disc Medicine, Inc.
- Stock
Last Close
63.51
22/11 17:29
Market Cap
1.89B
Beta: -
Volume Today
63.32K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | |||||
average payables | 1.28M - | 9.36M 630.25% | 14.40M 53.79% | ||
average receivables | |||||
book value per share | 77.58 - | -14.62 118.84% | 33.98 332.44% | 15.47 54.48% | |
capex per share | -0.01 - | -0.02 6.37% | -0.03 87.65% | -0.00 86.27% | |
capex to depreciation | -0.07 - | -2.13 3,010.23% | -1.70 20.16% | -0.89 47.54% | |
capex to operating cash flow | 0.00 - | 0.00 267.17% | 0.00 44.71% | 0.00 66.10% | |
capex to revenue | |||||
cash per share | 0.80 - | 20.04 2,399.62% | 37.44 86.80% | 16.15 56.87% | |
days of inventory on hand | |||||
days payables outstanding | |||||
days sales outstanding | |||||
debt to assets | 0.02 - | 0.01 62.75% | 0.01 14.32% | ||
debt to equity | -0.03 - | 0.01 129.34% | 0.01 19.41% | ||
dividend yield | |||||
earnings yield | -0.10 - | -0.11 11.92% | -0.45 316.89% | -0.06 86.70% | |
enterprise value | 497.59M - | 297.04M 40.30% | -89.90M 130.27% | 930.68M 1,135.25% | |
enterprise value over ebitda | -14.77 - | -11.49 22.22% | 1.89 116.48% | -10.21 639.35% | |
ev to operating cash flow | -15.21 - | -10.79 29.09% | 2.13 119.72% | -12.67 695.43% | |
ev to sales | |||||
free cash flow per share | -21.65 - | -6.28 70.98% | -8.16 29.82% | -3.30 59.60% | |
free cash flow yield | -0.07 - | -0.07 9.71% | -0.41 469.78% | -0.06 86.09% | |
graham net net | -2.39 - | -15.61 553.45% | 32.90 310.72% | 15.12 54.03% | |
graham number | 234.62 - | 55.41 76.38% | 82.34 48.59% | 34.52 58.07% | |
income quality | 0.80 - | 0.77 4.43% | 0.90 17.87% | 0.96 6.53% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -4.99 - | -14.33 187.44% | 64.42 549.39% | ||
interest debt per share | 4.52 - | 0.87 80.79% | 0.11 86.76% | 0.09 18.04% | |
inventory turnover | |||||
invested capital | -0.03 - | 0.01 129.34% | 0.01 19.41% | ||
market cap | 498.80M - | 383.42M 23.13% | 103.38M 73.04% | 1.29B 1,146.86% | |
net current asset value | -3.49M - | -66.13M 1,797.13% | 174.89M 364.46% | 342.79M 96.01% | |
net debt to ebitda | 0.04 - | 3.34 9,185.46% | 4.07 21.83% | 3.93 3.42% | |
net income per share | -31.53 - | -9.34 70.39% | -8.87 5.02% | -3.42 61.38% | |
operating cash flow per share | -21.64 - | -6.27 71.03% | -8.13 29.67% | -3.29 59.51% | |
payables turnover | |||||
receivables turnover | |||||
research and ddevelopement to revenue | |||||
return on tangible assets | -0.39 - | -0.44 13.66% | -0.23 48.12% | -0.21 9.78% | |
revenue per share | |||||
roe | -0.41 - | 0.64 257.14% | -0.26 140.86% | -0.22 15.15% | |
roic | -0.34 - | 0.58 270.92% | -0.26 145.01% | -0.26 0.21% | |
sales general and administrative to revenue | |||||
shareholders equity per share | 77.58 - | -14.62 118.84% | 33.98 332.44% | 15.47 54.48% | |
stock based compensation to revenue | |||||
tangible asset value | 117.27M - | -64.20M 154.75% | 176.60M 375.07% | 345.12M 95.43% | |
tangible book value per share | 77.58 - | -14.62 118.84% | 33.98 332.44% | 15.47 54.48% | |
working capital | 740.47K - | 77.06M 10,306.95% | 175.91M 128.28% | 344.22M 95.68% |
All numbers in (except ratios and percentages)